4D Molecular Therapeutics (FDMT) Interest & Investment Income (2020 - 2026)
4D Molecular Therapeutics (FDMT) reported Interest & Investment Income of $4.9 million for Q1 2026, down 12.86% year-over-year from $5.6 million in Q1 2025, and up 3.4% quarter-over-quarter from $4.7 million in Q4 2025.
4D Molecular Therapeutics (FDMT) Interest & Investment Income (2020 - 2026) Analysis & Trends
4D Molecular Therapeutics (FDMT) has 7 years of Interest & Investment Income data on file, last reported at $4.9 million in Q1 2026.
- Interest & Investment Income for Q1 2026 came in at $4.9 million, down 12.86% year-over-year; the trailing twelve-month figure through Mar 2026 was $18.8 million (down 30.24% YoY), and the FY2025 annual result was $19.5 million, down 28.0% from the prior year.
- Interest & Investment Income rose to $4.9 million in Q1 2026 per FDMT's latest filing, from $4.7 million in the prior quarter.
- Over five years, Interest & Investment Income peaked at $7.5 million in Q2 2024 and troughed at $100000.0 in Q1 2022.
- A 5-year average of $3.9 million and a median of $4.4 million in 2023 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2022 and 2025: Interest & Investment Income soared 4757.14% in 2022, then slumped 40.6% in 2025.
- A 5-year view of Interest & Investment Income shows it stood at $1.3 million in 2022, then jumped by 227.35% to $4.4 million in 2023, then surged by 47.65% to $6.5 million in 2024, then fell by 27.26% to $4.7 million in 2025, then climbed by 3.4% to $4.9 million in 2026.
- Business Quant data shows FDMT's Interest & Investment Income at $4.9 million in Q1 2026, $4.7 million in Q4 2025, and $4.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | 4D Molecular Therapeutics | 656.48 Mn | 656.48 Mn | - | 4.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.86 Mn |
| Dec 31, 2025 | 4.70 Mn |
| Sep 30, 2025 | 4.33 Mn |
| Jun 30, 2025 | 4.86 Mn |
| Mar 31, 2025 | 5.58 Mn |
| Dec 31, 2024 | 6.47 Mn |
| Sep 30, 2024 | 7.29 Mn |
| Jun 30, 2024 | 7.55 Mn |
| Mar 31, 2024 | 5.75 Mn |
| Dec 31, 2023 | 4.38 Mn |
| Sep 30, 2023 | 3.88 Mn |
| Jun 30, 2023 | 2.51 Mn |
| Mar 31, 2023 | 1.44 Mn |
| Dec 31, 2022 | 1.34 Mn |
| Sep 30, 2022 | 795,000.00 |
| Jun 30, 2022 | 340,000.00 |
| Mar 31, 2022 | 100,000.00 |
| Dec 31, 2021 | -312,000.00 |
| Sep 30, 2021 | 435,000.00 |
| Jun 30, 2021 | 7,000.00 |